ClinicalTrials.Veeva

Menu

Study on the Mechanism of Neurodevelopment Dysplasia of Fetal Brain Caused by ASNS Gene Mutation

J

Jilin University

Status

Unknown

Conditions

Asparagine Synthetase Deficiency
Genetic Diseases, Inborn

Study type

Observational

Funder types

Other

Identifiers

NCT03587155
ASNS-BRAIN001

Details and patient eligibility

About

The investigators propose to analyze a brain sample and/or peripheral blood by single cell RNA seq from aborted embryos with ASNS mutation.

Full description

Congenital microcephaly could cause by gene mutation. Asparagine synthetase deficiency, which is caused by ASNS mutation, is a rare autosomal recessive neurometabolic disorder. It is characterized by severe developmental delay, congenital microcephaly, seizures. The investigators found a family with ASNS mutaion. The investigators propose to analyze a brain sample and/or peripheral blood by single cell RNA seq from aborted embryos with ASNS mutation.

Enrollment

10 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Mutation Group: Having ASNS gene mutation by DNA exon sequencing.
  • Control Group: No ASNS gene mutation by DNA exon sequencing.

Exclusion criteria

  • Mutation Group: N/A.
  • Control Group: Having other gene mutation which also effect neurodevelopment.

Trial design

10 participants in 2 patient groups

Mutation
Description:
Embryo or infant with ASNS mutation.
Control
Description:
Embryo or infant without ASNS mutation.

Trial contacts and locations

1

Loading...

Central trial contact

Xinyu Hong, M.D., Ph.D.; Bo Chen, M.D., Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems